NCT05400824Recruiting
Metabolic and Infectious Diseases in La Réunion (the REUNION Population-based Study)
Pathologies métaboliques et Infectieuses en Population générale à La Réunion : étude REUNION
Source: ClinicalTrials.gov · Last updated 10 Jul 2026
Brief summary (registry, in English)
The aim of the present study is to determine the prevalence of cardiometabolic and infectious disease in La Reunion (french oversea department and region of France). Known or suspected risk factor for these diseases will also be assessed, such as microbiota, cognitive impairement, social inequalities, and genetics.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 27 May 2022
- Start date
- 1 May 2022
- Primary completion date
- Dec 2027
- Lead sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Diseases
- High blood pressure
- NCT number
- NCT05400824
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 1 May 2022 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- judicial protection or guardianship
Who the study is looking for
- 18-67 years
- given consent for genetic analysis,
- written consent for participating in the study
Age in the registry: 18 years to 67 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier Universitaire de la Réunion Coordinator of this site? Confirm its status | La Réunion. | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.